Diagnostics & Testing

Genomics England is a UK government-owned genomics organization partnering with the NHS to deliver whole genome sequencing diagnostics and operate a secure research environment. It manages the National Genomic Research Library with 140,000+ whole genomes and supports research in rare diseases, cancer, and personalized medicine through approved data access and collaborative initiatives.

Biognosys, presented here as Global Proteomics, is a private proteomics CRO and diagnostics-oriented life sciences company. It offers next-generation proteomics services, software, and consumables for biomarker discovery, clinical research, and precision medicine.

Pharmagene Discovery Services is a human tissue research CRO near Cambridge, UK, specialising in ethically sourced human biospecimens, translational human tissue and cell models, and tailored assay development. With a 30-year heritage, an HTA licence since 2007, and an 80,000-sample human tissue biorepository, it supports preclinical and clinical therapeutic and biomarker programmes for global biopharma clients.

INDICAL BIOSCIENCE is a Leipzig‑based veterinary diagnostics company providing complete molecular and immunological testing workflows for livestock, poultry and companion animals. Its portfolio spans automated nucleic acid extraction (IndiMag), pathogen‑specific qPCR and ELISA assays, and AI‑powered fecal analyzers (OvaCyte), supported by global distribution and specialist technical support.

INmune Bio Inc. is a NASDAQ-listed, clinical-stage biotech developing innate immune system therapies for Alzheimer’s disease and cancer. Its pipeline includes XPro1595 for neuroinflammation in early Alzheimer’s and INKmune/INB03 for oncology, guided by a biomarker-driven, patient-centric clinical development strategy.

Serimmune Inc. is an immune intelligence company providing advanced immune profiling and antibody testing solutions based on its SERA platform. Using peptide display libraries, sequencing, and machine learning, Serimmune supports biomarker discovery, multiplex diagnostics, infectious disease panels, and population serosurveillance from small-volume serum samples.

Immunexpress Inc. is a privately held molecular diagnostics company founded in 2006, headquartered in Seattle with offices in Brisbane. The company develops SeptiCyte® host-response diagnostic tests, including SeptiCyte® RAPID, an FDA-cleared, CE-marked, and TGA-cleared PCR-based assay that differentiates sepsis from non-infectious inflammation in approximately one hour.

InnoSIGN was a precision medicine company that commercialized the OncoSIGNal™ mRNA-based pathway activity profiling platform to interpret gene expression and multi-omics data for drug discovery, diagnostics, and treatment selection. It offered cloud-based analysis and test solutions to quantify signal transduction pathway activity in cancer and immune cells before ceasing operations, with its website now maintained as an archive.

Biohit is a Finnish public healthtech company specializing in gastrointestinal diagnostics and related products. It is headquartered in Helsinki and markets products such as GastroPanel, biopsy quick tests for lactose intolerance and H. pylori, and Acetium.

InterVenn Biosciences is a private life sciences company using AI-driven glycoproteomics to develop diagnostics and precision medicine solutions. Its proprietary platform enables biomarker discovery, treatment response prediction, and non-invasive tests, particularly in oncology. Headquartered in South San Francisco, InterVenn partners with biopharma and clinical researchers to integrate glycoproteomic insights into clinical workflows.

n6 develops the iconPCR platform, a real‑time NGS library prep thermocycler with AutoNorm adaptive amplification for per‑well cycle control and built‑in normalization. iconPCR and the icon96/icon16 instruments support 16S metagenomics, RNA‑seq, single‑cell and WGS workflows, helping labs cut manual quantification and normalization, reduce failures in low‑input or FFPE samples, and generate consistent, sequencing‑ready libraries in one automated step.

SCIEX is a leading provider of LC‑MS, capillary electrophoresis and analytical software solutions used across clinical diagnostics, environmental and food testing, forensics and pharma/biopharma research. Its portfolio includes mass spectrometers, clinical IVD devices, CE instruments, HPLC‑MS front‑ends, SCIEX OS software and integrated workflows, all supported by a global service network and Danaher’s Life Sciences platform.

Source BioScience is a UK-headquartered provider of integrated laboratory services in genomics, proteomics, histopathology, digital pathology and molecular diagnostics for pharma, biotech, healthcare and academia. Through Source Genomics and Source LDPath, it offers multi-omic sequencing, proteomic analysis and end-to-end clinical diagnostic workflows from ISO-accredited laboratories with rapid turnaround times.

Primerdesign is a molecular diagnostics company specializing in real-time qPCR assays, kits and workflows for human healthcare, food, water, agriculture and veterinary applications. With over 20 years’ experience and more than 1,200 assays developed for customers in 100+ countries, it offers ready-to-deploy open-platform qPCR products, OEM-ready kits, custom assay development and instrumentation to support high-performance molecular detection and outbreak surveillance.

Amsbio (Life Science Products & Solutions) is a global supplier of life science reagents and custom services, offering over 1.75 million products to support pharma, biotech, and academic research. Its portfolio spans antibodies, assays, cell culture, molecular biology, proteins, cryopreservation, and biofluids, complemented by protein expression, viral vector, tissue procurement, drug screening, and cell-based assay services for discovery and translational R&D.

LGC Group is a UK-headquartered life sciences tools and standards company serving pharma, diagnostics, and research markets. Its core strengths include life-science reagents, reference materials, quality management tools, and compliance-oriented support for assay development and laboratory workflows.

LifeArc is a UK life-science charity focused on translational research, diagnostics, biomarker development, antibody humanisation, and drug development. It supports pharma and R&D buyers through scientific expertise, funding, partnerships, and investment in early-stage ventures.

Lipotype GmbH is a Dresden-based biotech company and leading lipidomics service provider for industry and academia. Its Lipotype Lipidomics platform offers high-throughput, mass spectrometry-based quantification of thousands of lipids, combined with advanced data analysis and reporting. Pharma, biotech, clinical, nutrition, cosmetics, and academic researchers use Lipotype for biomarker discovery, mechanistic studies, and decision-ready lipidomics data.

Luminex’s Licensed Technology group, part of DiaSorin, delivers xMAP® multiplexing platforms and MagPlex® microspheres that enable high‑plex protein and nucleic acid assays from minimal sample volume. These licensed tools support diagnostics, bio‑pharma R&D and public health applications across transplant, autoimmune, infectious disease, oncology, allergy, microbiome and more, backed by resources like the xMAP® Kit Finder and Cookbook.

MGI Tech is a Chinese biotechnology company founded in 2016, developing sequencing platforms, lab automation systems, and multi-omics technologies for pharmaceutical R&D and diagnostics. Headquartered in Shenzhen with approximately 2,200 employees, the company serves over 3,800 global users through its DNBSEQ sequencing platforms, GLI automation solutions, and spatial transcriptomics technologies.

MOBILion Systems develops SLIM‑based high‑resolution ion mobility mass spectrometry platforms that deliver superior resolution, faster analysis, and highly reproducible characterization of complex molecules. Its MOBIE system supports workflows such as lipidomics, glycan analysis, PFAS, and biotherapeutic characterization for research use in pharma, diagnostics, and food and environmental testing.

Tagomics is a UK-based multiomics biomarker discovery and diagnostics company focused on precision medicine. Its public website is currently a placeholder, so most visible facts come from company registry and third-party company descriptions rather than a detailed official product catalog.

Lunaphore, a Bio-Techne Spatial brand based in Switzerland, provides automated spatial biology platforms for high‑plex IF/IHC and multiomics on tissue. Its COMET™ instrument, SPYRE™ panels, HORIZON™ software and Access Lab services help pharma and biotech teams rapidly develop and scale spatial biomarker programs across translational and clinical research.

Oxford Nanopore Technologies (Nanoporetech) provides nanopore-based DNA/RNA sequencing platforms, library prep kits and analysis software for real-time, information‑rich genomics. Its scalable devices, including the portable MinION and high‑output PromethION flow cells, support applications such as cancer research, hereditary disease, microbiology and metagenomics, with diagnostics‑oriented offerings under Oxford Nanopore Diagnostics.